temozolomide has been researched along with aminolevulinic acid in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
Kern, BC; Krex, D; Mehdorn, HM; Nestler, U; Pichlmeier, U; Stockhammer, F; Stummer, W; Vince, GH | 1 |
Arza, C; Díez Valle, R; Galván, J; Romariz, C; Slof, J; Vidal, C | 1 |
Buchner, A; Lyu, C; Pohla, H; Schrader, I; Sroka, R; Stadlbauer, B; Stepp, H; Werner, M | 1 |
Aboukaïs, R; Bourgeois, P; Devalckeneer, A; Lejeune, JP; Reyns, N | 1 |
1 trial(s) available for temozolomide and aminolevulinic acid
Article | Year |
---|---|
Favorable outcome in the elderly cohort treated by concomitant temozolomide radiochemotherapy in a multicentric phase II safety study of 5-ALA.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Female; Glioma; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Male; Middle Aged; Photosensitizing Agents; Radiotherapy; Temozolomide; Treatment Outcome | 2011 |
4 other study(ies) available for temozolomide and aminolevulinic acid
Article | Year |
---|---|
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study).
Topics: Aminolevulinic Acid; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Female; Glioma; Humans; Male; Middle Aged; Neurosurgical Procedures; Photosensitizing Agents; Retrospective Studies; Surgery, Computer-Assisted; Temozolomide; Treatment Outcome | 2014 |
The role of Shikonin in improving 5-aminolevulinic acid-based photodynamic therapy and chemotherapy on glioblastoma stem cells.
Topics: Aminolevulinic Acid; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Naphthoquinones; Neoplasm Recurrence, Local; Photochemotherapy; RNA, Messenger; Temozolomide | 2022 |
Supraorbital transciliary approach as primary route to fronto-basal high grade glioma resection with 5-Aminolevulinic Acid use: Technical note.
Topics: Aminolevulinic Acid; Brain Neoplasms; Glioblastoma; Glioma; Humans; Neoplasm Recurrence, Local; Temozolomide | 2023 |